What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Disease
- Surgery
His main research concerns Internal medicine, Vasculitis, Surgery, Gastroenterology and Systemic vasculitis.
His study in Cyclophosphamide, Rheumatology, Rheumatism, Rituximab and Lupus nephritis is carried out as part of his studies in Internal medicine.
His work deals with themes such as Antibody, Immunology and Intensive care medicine, which intersect with Vasculitis.
His Gastroenterology research includes elements of Creatinine, Placebo and Azathioprine.
His work in Systemic vasculitis covers topics such as Retrospective cohort study which are related to areas like Polyarteritis nodosa.
His research investigates the connection between Anti-neutrophil cytoplasmic antibody and topics such as Microscopic polyangiitis that intersect with problems in Granulomatosis with polyangiitis.
His most cited work include:
- 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides (2901 citations)
- A Randomized Trial of Maintenance Therapy for Vasculitis Associated with Antineutrophil Cytoplasmic Autoantibodies (1073 citations)
- Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis (1036 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Internal medicine, Vasculitis, Immunology, Rituximab and Gastroenterology.
His research investigates the connection between Internal medicine and topics such as Surgery that intersect with issues in Adverse effect.
Vasculitis is a primary field of his research addressed under Pathology.
The various areas that David Jayne examines in his Immunology study include Lupus nephritis, Disease and Clinical trial.
His studies in Rituximab integrate themes in fields like Hypogammaglobulinemia, Autoimmune disease and Prednisone.
His work carried out in the field of Gastroenterology brings together such families of science as Creatinine, Kidney and Renal function.
He most often published in these fields:
- Internal medicine (53.52%)
- Vasculitis (48.46%)
- Immunology (29.74%)
What were the highlights of his more recent work (between 2019-2021)?
- Internal medicine (53.52%)
- Vasculitis (48.46%)
- Rituximab (21.59%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Internal medicine, Vasculitis, Rituximab, Granulomatosis with polyangiitis and Microscopic polyangiitis.
His Internal medicine study frequently draws connections to other fields, such as Gastroenterology.
His Vasculitis study combines topics from a wide range of disciplines, such as Cyclophosphamide and Immunology.
His Rituximab research is multidisciplinary, relying on both Prednisolone, Hypogammaglobulinemia, Azathioprine, Prednisone and Dosing.
David Jayne works mostly in the field of Granulomatosis with polyangiitis, limiting it down to concerns involving Eosinophilic and, occasionally, Myeloperoxidase and Proteinase 3.
His Systemic vasculitis study which covers Regimen that intersects with Prospective cohort study.
Between 2019 and 2021, his most popular works were:
- Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis (90 citations)
- 2019 Update of the Joint European League against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis (67 citations)
- ANCA-associated vasculitis. (24 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Surgery
David Jayne focuses on Internal medicine, Vasculitis, Rituximab, Microscopic polyangiitis and Granulomatosis with polyangiitis.
His study ties his expertise on Gastroenterology together with the subject of Internal medicine.
His Vasculitis study frequently draws parallels with other fields, such as Immunology.
The Rituximab study combines topics in areas such as Maintenance therapy, Azathioprine, ANCA-Associated Vasculitis and Cyclophosphamide.
His Microscopic polyangiitis research incorporates themes from Alternative complement pathway, Complement factor B, Complement system, Anti-neutrophil cytoplasmic antibody and Systemic vasculitis.
His Granulomatosis with polyangiitis research is multidisciplinary, incorporating perspectives in Mononeuritis Multiplex, Polyarthritis, Asthma, Properdin and Complement membrane attack complex.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
